421 related articles for article (PubMed ID: 36012327)
1. Psoriasis and Cardiometabolic Diseases: Shared Genetic and Molecular Pathways.
Piaserico S; Orlando G; Messina F
Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012327
[TBL] [Abstract][Full Text] [Related]
2. Cardiovascular Considerations and Implications for Treatment in Psoriasis: An Updated Review.
Mehta H; Narang T; Dogra S; Handa S; Hatwal J; Batta A
Vasc Health Risk Manag; 2024; 20():215-229. PubMed ID: 38745849
[TBL] [Abstract][Full Text] [Related]
3. Psoriasis and Cardiovascular Comorbidities: Focusing on Severe Vascular Events, Cardiovascular Risk Factors and Implications for Treatment.
Hu SC; Lan CE
Int J Mol Sci; 2017 Oct; 18(10):. PubMed ID: 29065479
[TBL] [Abstract][Full Text] [Related]
4. Cardiometabolic comorbidities and the approach to patients with psoriasis.
Gisondi P; Girolomoni G
Actas Dermosifiliogr; 2009 Dec; 100 Suppl 2():14-21. PubMed ID: 20096157
[TBL] [Abstract][Full Text] [Related]
5. Cardiometabolic risk in psoriasis: differential effects of biologic agents.
Kaplan MJ
Vasc Health Risk Manag; 2008; 4(6):1229-35. PubMed ID: 19337536
[TBL] [Abstract][Full Text] [Related]
6. Killing Two Birds with One Stone: Potential Therapies Targeting Psoriasis and Atherosclerosis at the Same Time.
Merzel Šabović EK; Starbek Zorko M; Janić M
Int J Mol Sci; 2022 Jun; 23(12):. PubMed ID: 35743091
[TBL] [Abstract][Full Text] [Related]
7. Psoriasis and cardiovascular disorders.
Frieder J; Ryan C
G Ital Dermatol Venereol; 2016 Dec; 151(6):678-693. PubMed ID: 27627099
[TBL] [Abstract][Full Text] [Related]
8. [Psoriasis and cardiovascular disease].
Torres T; Sales R; Vasconcelos C; Selores M
Acta Med Port; 2013; 26(5):601-7. PubMed ID: 24192101
[TBL] [Abstract][Full Text] [Related]
9. The concept of psoriasis as a systemic inflammation: implications for disease management.
Reich K
J Eur Acad Dermatol Venereol; 2012 Mar; 26 Suppl 2():3-11. PubMed ID: 22356630
[TBL] [Abstract][Full Text] [Related]
10. Psoriasis, Cardiovascular Events, and Biologics: Lights and Shadows.
Caiazzo G; Fabbrocini G; Di Caprio R; Raimondo A; Scala E; Balato N; Balato A
Front Immunol; 2018; 9():1668. PubMed ID: 30150978
[TBL] [Abstract][Full Text] [Related]
11. Interleukin-17 Links Inflammatory Cross-Talks Between Comorbid Psoriasis and Atherosclerosis.
Wang Y; Zang J; Liu C; Yan Z; Shi D
Front Immunol; 2022; 13():835671. PubMed ID: 35514987
[TBL] [Abstract][Full Text] [Related]
12. Underdiagnosis and undertreatment of cardiovascular risk factors in patients with moderate to severe psoriasis.
Kimball AB; Szapary P; Mrowietz U; Reich K; Langley RG; You Y; Hsu MC; Yeilding N; Rader DJ; Mehta NN
J Am Acad Dermatol; 2012 Jul; 67(1):76-85. PubMed ID: 22018756
[TBL] [Abstract][Full Text] [Related]
13. Metabolic profiling reveals interleukin-17A monoclonal antibody treatment ameliorate lipids metabolism with the potentiality to reduce cardiovascular risk in psoriasis patients.
Cao H; Su S; Yang Q; Le Y; Chen L; Hu M; Guo X; Zheng J; Li X; Yu Y
Lipids Health Dis; 2021 Feb; 20(1):16. PubMed ID: 33602246
[TBL] [Abstract][Full Text] [Related]
14. From the Medical Board of the National Psoriasis Foundation: The risk of cardiovascular disease in individuals with psoriasis and the potential impact of current therapies.
Hugh J; Van Voorhees AS; Nijhawan RI; Bagel J; Lebwohl M; Blauvelt A; Hsu S; Weinberg JM
J Am Acad Dermatol; 2014 Jan; 70(1):168-77. PubMed ID: 24184141
[TBL] [Abstract][Full Text] [Related]
15. Psoriasis: the visible killer.
Torres T; Bettencourt N
Rev Port Cardiol; 2014 Feb; 33(2):95-9. PubMed ID: 24525359
[TBL] [Abstract][Full Text] [Related]
16. Interleukin-17 as a factor linking the pathogenesis of psoriasis with metabolic disorders.
Owczarczyk-Saczonek A; Placek W
Int J Dermatol; 2017 Mar; 56(3):260-268. PubMed ID: 27696392
[TBL] [Abstract][Full Text] [Related]
17. The role of the interleukin-23/Th17 pathway in cardiometabolic comorbidity associated with psoriasis.
Egeberg A; Gisondi P; Carrascosa JM; Warren RB; Mrowietz U
J Eur Acad Dermatol Venereol; 2020 Aug; 34(8):1695-1706. PubMed ID: 32022950
[TBL] [Abstract][Full Text] [Related]
18. Compounds of psoriasis with obesity and overweight.
Owczarczyk-Saczonek A; Placek W
Postepy Hig Med Dosw (Online); 2017 Aug; 71(1):761-772. PubMed ID: 28894050
[TBL] [Abstract][Full Text] [Related]
19. The 'psoriatic march': a concept of how severe psoriasis may drive cardiovascular comorbidity.
Boehncke WH; Boehncke S; Tobin AM; Kirby B
Exp Dermatol; 2011 Apr; 20(4):303-7. PubMed ID: 21410760
[TBL] [Abstract][Full Text] [Related]
20. Genetic markers for cardiovascular disease in psoriasis: the missing piece.
Torres T; Chiricozzi A; Chimenti S; Saraceno R
Mol Diagn Ther; 2014 Feb; 18(1):93-5. PubMed ID: 24078347
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
